Tesla's (TSLA 3.19%) original vision a little over two decades ago once seemed like a pipe dream to many. The electric vehicle (EV) maker started with the Roadster, and the idea that it could slowly build a brand, scale, and demand for EVs on a global mass-market level and do so profitably. With that vision largely accomplished, Tesla's focus jumped ahead into the possibilities of robotics, artifi...
Tesla's (TSLA 3.19%) original vision a little over two decades ago once seemed like a pipe dream to many. The electric vehicle (EV) maker started with the Roadster, and the idea that it could slowly build a brand, scale, and demand for EVs on a global mass-market level and do so profitably. With that vision largely accomplished, Tesla's focus jumped ahead into the possibilities of robotics, artificial intelligence (AI), and driverless vehicles. Many Tesla investors thought the company would be leaving the auto industry and its rivals behind -- but now a strangely familiar face has joined Tesla in its new ambitions. What's going on? Some Tesla investors assumed the company would leave its auto rivals in the dust as its focus pivoted. Not only has an automaker set its sights on some of the same future endeavors as Tesla, it's probably not the automaker investors would have expected. South Korean automaker Hyundai Motor Group recently announced it would invest $6 billion in a new high-tech robot. The South Korean plant will not only build robots developed in-house, it will have a massive solar-powered hydrogen production facility and a data center to support its AI capability in future products. While few automakers have been brave enough to put their money where their mouth is for new mobility businesses and advanced manufacturing, Tesla, Hyundai, BMW, Mercedes-Benz, and Toyota are some others working on humanoid robots to at least deploy on assembly lines, if not more broadly. Hyundai's stock price soared with the announcement, and Morgan Stanley's analysts project that the humanoid robotics market could reach $5 trillion by 2050. Savvy investors might not be surprised by Tesla's strangely familiar robotic rival, considering Hyundai acquired Boston Dynamics in 2021 and then introduced its bipedal Atlas droid at CES in January 2026. At about the time Hyundai acquired Boston Dynamics, Tesla was announcing its humanoid robot plans at its AI Day in August 2021, with a hu...
Key Points Tesla is making a massive strategic pivot to focus on AI, robotics, and driverless vehicles. Hyundai just announced a $6 billion investment to create a new high-tech robot. Humanoid robotics are estimated to be a $5 trillion market by 2050. These 10 stocks could mint the next wave of millionaires › Tesla's (NASDAQ: TSLA) original vision a little over two decades ago once seemed like a p...
Key Points Tesla is making a massive strategic pivot to focus on AI, robotics, and driverless vehicles. Hyundai just announced a $6 billion investment to create a new high-tech robot. Humanoid robotics are estimated to be a $5 trillion market by 2050. These 10 stocks could mint the next wave of millionaires › Tesla's (NASDAQ: TSLA) original vision a little over two decades ago once seemed like a pipe dream to many. The electric vehicle (EV) maker started with the Roadster, and the idea that it could slowly build a brand, scale, and demand for EVs on a global mass-market level and do so profitably. With that vision largely accomplished, Tesla's focus jumped ahead into the possibilities of robotics, artificial intelligence (AI), and driverless vehicles. Many Tesla investors thought the company would be leaving the auto industry and its rivals behind -- but now a strangely familiar face has joined Tesla in its new ambitions. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » What's going on? Some Tesla investors assumed the company would leave its auto rivals in the dust as its focus pivoted. Not only has an automaker set its sights on some of the same future endeavors as Tesla, it's probably not the automaker investors would have expected. South Korean automaker Hyundai Motor Group recently announced it would invest $6 billion in a new high-tech robot. The South Korean plant will not only build robots developed in-house, it will have a massive solar-powered hydrogen production facility and a data center to support its AI capability in future products. While few automakers have been brave enough to put their money where their mouth is for new mobility businesses and advanced manufacturing, Tesla, Hyundai, BMW, Mercedes-Benz, and Toyota are some others working on humanoid robots to at least deploy on ass...
Photo: VCG Wang Zhaoxing, a veteran Chinese financial regulator known for his role in shaping banking supervision and opening the sector to global standards, has died at 67, according to multiple industry sources. Wang, a former vice chairman of the now-defunct China Banking and Insurance Regulatory Commission (CBIRC) and a State Council counselor, died Tuesday, Caixin learned from several industr...
Photo: VCG Wang Zhaoxing, a veteran Chinese financial regulator known for his role in shaping banking supervision and opening the sector to global standards, has died at 67, according to multiple industry sources. Wang, a former vice chairman of the now-defunct China Banking and Insurance Regulatory Commission (CBIRC) and a State Council counselor, died Tuesday, Caixin learned from several industry insiders.
If you were born in 1960 or later, once you turn 67, you'll reach full retirement age and become eligible for your Social Security benefits without a reduction. But a lot of early retirees don't wait that long. Social Security benefits become available at age 62. If you're retiring early, you may decide to claim Social Security ahead of full retirement age so you're able to cover your costs. And y...
If you were born in 1960 or later, once you turn 67, you'll reach full retirement age and become eligible for your Social Security benefits without a reduction. But a lot of early retirees don't wait that long. Social Security benefits become available at age 62. If you're retiring early, you may decide to claim Social Security ahead of full retirement age so you're able to cover your costs. And you may need to claim Social Security early if you don't have much or any savings for retirement. If you're an early retiree who's claimed Social Security prior to full retirement age, you should know that you're allowed to earn money from a job while collecting benefits. But you'll also, in that case, be subject to an earnings test. And it's important to know how it works. The ins and outs of Social Security's earnings test Social Security's earnings test applies to beneficiaries who haven't reached full retirement age. It sets limits on how much you can earn each year before having benefits withheld. In 2026, you'll have $1 in Social Security withheld per $2 of earnings beyond $24,480 if you won't be reaching full retirement age at any point. If you will be reaching full retirement age by the end of the year, the formula loosens up quite a bit. In that case, you'll have $1 in Social Security withheld per $3 of earnings beyond $65,160. If you have benefits withheld due to exceeding the earnings-test limit, that money will be paid back to you. Once you reach full retirement age, the Social Security Administration will recalculate your monthly benefits and start sending you larger monthly checks. However, when you claim Social Security ahead of full retirement age, your monthly benefits are generally permanently reduced. There's little sense in taking that hit if you're looking at withheld benefits anyway. It's important to know the rules It's crucial to read up on Social Security's rules regardless of when you're thinking of claiming benefits. But it's especially important t...
Economists are shifting to align with the market view that European Central Bank interest-rate hikes are inevitable within months. The escalation of the conflict in the Middle East, combined with hawkish comments from policymakers on Thursday, prompted analysts from JP Morgan, Morgan Stanley and Deutsche Bank to change their calls for borrowing costs in the euro zone. JP Morgan now sees increases ...
Economists are shifting to align with the market view that European Central Bank interest-rate hikes are inevitable within months. The escalation of the conflict in the Middle East, combined with hawkish comments from policymakers on Thursday, prompted analysts from JP Morgan, Morgan Stanley and Deutsche Bank to change their calls for borrowing costs in the euro zone. JP Morgan now sees increases in April and July. The other two predict a slower response, with moves in June and September. “To manage the risk, we now expect the ECB to hike rates to 2.5%, the upper end of the range of neutral,” Deutsche Bank economists led by Mark Wall said in a report. “This would send a message of commitment to price stability without imposing a significant cost on growth.” While the ECB kept rates unchanged for a sixth meeting this week, officials would be ready to raise borrowing costs on April 30, should fallout from the war push inflation too far above target, people familiar with the situation told Bloomberg on Thursday. That chimes with the view of Bundesbank President Joachim Nagel , who said in an interview published on Friday that policymakers will need to consider hiking rates as soon as next month if price pressures build further due to the Iran war. ECB Would Need April Hike If Price Outlook Sours, Nagel Says ECB Officials See Possibility of Rate Hike at April Meeting Lagarde Says ECB Well Placed to Handle War Risks as Rates Held Money markets are currently betting on two quarter-point hikes from the ECB this year, with the first potentially as soon as April. There’s a more than 50% chance of a third hike by the end of the year, based on swaps pricing. Both JP Morgan and Morgan Stanley reckon the central bank will ultimately at least partially reverse its moves. “Faced with lower growth, we think the ECB will likely cut rates again in June and September 2027 to 2%, bringing rates back to neutral territory,” Morgan Stanley economists led by Jens Eisenschmidt said in a rep...
TBE/iStock Editorial via Getty Images Novartis ( NVS ) has agreed to buy an experimental breast cancer drug from Synnovation Therapeutics for as much as $3B to support its oncology strategy in HR+/HER2- breast cancer. SNV4818 is an oral drug currently being evaluated in a Phase 1/2 study for breast cancer and other advanced solid tumors. Preclinical studies show strong activity against common PIK3...
TBE/iStock Editorial via Getty Images Novartis ( NVS ) has agreed to buy an experimental breast cancer drug from Synnovation Therapeutics for as much as $3B to support its oncology strategy in HR+/HER2- breast cancer. SNV4818 is an oral drug currently being evaluated in a Phase 1/2 study for breast cancer and other advanced solid tumors. Preclinical studies show strong activity against common PIK3CA mutations and clear selectivity over the normal enzyme, with clinical evaluation ongoing. The drug is designed to target the mutated PI3Kα enzyme found in cancer cells while sparing the wild-type (normal) PI3Kα in healthy cells. By focusing on the mutated form in tumors, SNV4818 aims to reduce unwanted side effects, support more consistent dosing, and make it easier to combine with hormonal therapy and other treatments earlier in care. Under the terms of the agreement , Novartis will pay $2B upfront and up to $1B in milestone payments to Synnovation Therapeutics to acquire Pikavation Therapeutics, a wholly- owned subsidiary of Synnovation that holds a portfolio of pan-mutant selective PI3Kα inhibitor programs, including SNV4818. The transaction is expected to close in H1 2026, subject to the satisfaction or waiver of customary closing conditions, including regulatory approvals. More on Novartis Novartis AG (NVS) Shareholder/Analyst Call Prepared Remarks Transcript Novartis: Value Price, Growth Pipeline Novartis AG 2025 Q4 - Results - Earnings Call Presentation Novartis picks Texas to build next radioligand therapy site Trump says tariffs prompt Novartis to expand U.S. manufacturing
A Historic Flip In Real Estate This rapid growth has pushed data center projects past general office construction, marking a permanent shift in how corporate America utilizes physical space. The ChatGPT Effect And Big Tech CapEx This unprecedented boom is being directly fueled by the artificial intelligence (AI) revolution. To support resource-heavy AI models, hyperscalers have aggressively ramped...
A Historic Flip In Real Estate This rapid growth has pushed data center projects past general office construction, marking a permanent shift in how corporate America utilizes physical space. The ChatGPT Effect And Big Tech CapEx This unprecedented boom is being directly fueled by the artificial intelligence (AI) revolution. To support resource-heavy AI models, hyperscalers have aggressively ramped up their capital expenditures (CapEx). The shift accelerated sharply following the public debut of generative AI. “Since November 2022, when ChatGPT was launched, data center construction is up +228%,” The Kobeissi Letter noted, concluding simply that “AI is reshaping the US economy.” The Decline Of Traditional Offices While the digital infrastructure sector thrives, traditional office construction continues to face a severe downturn, still grappling with the long-term impacts of remote work and shifting corporate priorities. The value of general offices currently under construction has fallen by 13% over the past year. Now sitting at just $43.5 billion, office development has officially hit its lowest point since October 2015. The contrast is staggering: over the exact same period that data center builds skyrocketed by over 200%, general office construction has plummeted by 38%. This stark divergence underscores a clear transition in the modern economy. As investments in the physical office fade, the digital data center is swiftly taking its place. AMZN And META Underperform In 2026 Shares of Amazon were down 9.56% year-to-date, and Meta declined 8.06%, while the Nasdaq 100 index tumbled 3.38% in the same period. However, over the last month, AMZN was up 1.90%, and META dropped 5.91%. Benzinga’s Edge Stock Rankings indicate that AMZN maintains a weak price trend over the long, short, and medium terms, with a solid growth score. Benzinga’s Edge Stock Rankings indicate that META maintains a weak price trend over the long, short, and medium terms, with a moderate value score...
Unilever ( UL ) announced that it received an inbound offer for its food business and is in discussions with McCormick ( MKC ). "The Board believes Foods is a highly attractive business, with a strong financial profile led by market-leading brands in growing categories and is confident in the future of the Foods business as part of Unilever," the company said in a statement . "While these discussi...
Unilever ( UL ) announced that it received an inbound offer for its food business and is in discussions with McCormick ( MKC ). "The Board believes Foods is a highly attractive business, with a strong financial profile led by market-leading brands in growing categories and is confident in the future of the Foods business as part of Unilever," the company said in a statement . "While these discussions are ongoing, there can be no certainty or assurances as to whether an agreement for a transaction will be reached or as to the terms or timing of any such transaction," McCormick ( MKC ) stated . An all-stock deal may be announced within weeks if talks don't fall apart, The Wall Street Journal reported , citing people familiar with the matter. The exact structure remains unknown. Unilever's ( UL ) food business, which houses brands such as Knorr and Hellmann's, could be worth tens of billions of dollars. McCormick's ( MKC ) products include Frank's RedHot sauce and French's yellow mustard. Unilever ( UL ) reportedly held talks with Kraft Heinz ( KHC ) over combining its food business with the latter's condiments division. The talks have since ended. Separating its food business would enable Unilever ( UL ) to focus on its larger beauty, personal care and home divisions. The company spun off its ice cream business Magnum last year. More on Unilever, McCormick Unilever: Relatively Anemic In 2026, I Say 'Hold' Unilever (UL) Presents at Consumer Analyst Group of New York Conference 2026 - Slideshow McCormick (MKC) Presents at Consumer Analyst Group of New York Conference 2026 Prepared Remarks Transcript McCormick Is No Longer Overvalued Kraft Heinz, Unilever held talks about a food merger - FT